Cargando…
Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study
AIMS: Type 2 diabetes is considered to be one of the essential risks of adverse outcomes in coronavirus disease 2019 (COVID-19). Metformin and insulin were suggested to affect the outcomes. However, divergent views are still expressed. We aim to gain further insight into metformin and insulin in bot...
Autores principales: | Cheng, Xueqi, Xin, Siyi, Chen, Yaqi, Li, Leyu, Chen, Wanjun, Li, Wenjia, Zhou, Baoan, Li, Chenxia, Gong, Yu, Li, Fei, Duan, Peng, Zhou, Xingjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972834/ https://www.ncbi.nlm.nih.gov/pubmed/33745895 http://dx.doi.org/10.1016/j.lfs.2021.119371 |
Ejemplares similares
-
CircRNA_0001795 sponges miRNA-339-5p to regulate yes-associated protein 1 expression and attenuate osteoporosis progression
por: Li, Mingyi, et al.
Publicado: (2022) -
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
por: Cheng, Xu, et al.
Publicado: (2020) -
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
por: Zhang, Yi, et al.
Publicado: (2023) -
Metformin and cancer: An existing drug for cancer prevention and therapy
por: Zi, Fuming, et al.
Publicado: (2018) -
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
por: Qi, Xiaolong, et al.
Publicado: (2021)